We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hodgkin lymphoma

News List

New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma prnasia
September 30, 2020
The National Comprehensive Cancer Network® (NCCN®) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma.
EC expands Takeda’s Adcetris authorisation for Hodgkin lymphoma pharmaceutical-technology
February 14, 2019
The European Commission (EC) has expanded the marketing authorisation of Takeda Pharmaceutical’s Adcetris (brentuximab vedotin) to adults with previously untreated CD30+ Stage IV Hodgkin lymphoma....
NICE recommends against Opdivo for classical Hodgkin lymphoma pharmafile
March 16, 2017
The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab)...
Hodgkin Lymphoma Survivors Face Risk of Second Cancer: Study drugs.com
March 14, 2017
The risk of developing a second type of cancer may be high among Hodgkin lymphoma survivors, especially those with a family history of cancer.